Clinical characteristics and outcomes of patients with Guillain-Barré and acquired CNS demyelinating overlap syndrome: A cohort study based on a literature review

Neurological Research

Volumn 36, Issue 12, 2014, Pages 1106-1113

  Mao, Zhifeng ^a,b   Hu, Xueqiang ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Central nervous system; Clinically isolated syndromes; Demyelinating diseases; Guillain Barr syndrome; Miller Fisher syndrome; Overlap syndrome; Transverse myelitis

Indexed keywords

ACUTE MOTOR AXONAL NEUROPATHY; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DEMYELINATING NEUROPATHY; ENCEPHALOMYELITIS; GUILLAIN BARRE SYNDROME; HUMAN; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PROGNOSIS; ADOLESCENT; ADULT; AGED; CHILD; COMPLICATION; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; GUILLAIN-BARRE SYNDROME; IMMUNOTHERAPY; MALE; MIDDLE AGED; PRESCHOOL CHILD; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOTHERAPY; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908198936     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132814Y.0000000400     Document Type: Article

References (66)

1. Bajaj NP, Rose P, Clifford-Jones R, Hughes PJ. Acute transverse myelitis and Guillain-Barre overlap syndrome with serological evidence for mumps viraemia. Acta Neurol Scand. 2001;104:239-42.
2. Nadkarni N, Lisak RP. Guillain-Barre syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology. 1993;43:842-3.
3. Lin JJ, Hsia SH, Wu CT, Wang HS, Lin KL, Lyu RK. Risk factors and outcomes of Guillain-Barre syndrome with acute myelitis. Pediatr Neurol. 2011;44:110-6.
4. Zephir H, Stojkovic T, Latour P, Lacour A, de Seze J, Outteryck O, et al. Relapsing demyelinating disease affecting both the central and peripheral nervous systems. J Neurol Neurosurg Psychiatry. 2008;79:1032-9.
5. Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599-612.
6. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68:S7-12.
7. Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011;77:1143-8.
8. Bernard G, Riou E, Rosenblatt B, Dilenge ME, Poulin C. Simultaneous Guillain-Barre syndrome and acute disseminated encephalomyelitis in the pediatric population. J Child Neurol. 2008;23:752-7.
9. Karimzadeh P, Khosroshahi N, Khatami AR. Acute combined demyelination of CNS and PNS: a case report. Iran J Radiol. 2007;5:93-6.
10. Huber S, Kappos L, Fuhr P, Wetzel S, Steck AJ. Combined acute disseminated encephalomyelitis and acute motor axonal neuropathy after vaccination for hepatitis A and infection with Campylobacter jejuni. J Neurol. 1999;246:1204-6.
11. Kinoshita A, Hayashi M, Miyamoto K, Oda M, Tanabe H. Inflammatory demyelinating polyradiculitis in a patient with acute disseminated encephalomyelitis (ADEM). J Neurol Neurosurg Psychiatry. 1996;60:87-90.
12. Amit R, Glick B, Itzchak Y, Dgani Y, Meyeir S. Acute severe combined demyelination. Childs Nerv Syst. 1992;8:354-6.
13. Amit R, Shapira Y, Blank A, Aker M. Acute, severe, central and peripheral nervous system combined demyelination. Pediatr Neurol. 1986;2:47-50.
14. Hawley RJ, Madrid R. Post-infectious central and peripheral nervous system diseases in patient with Devic’s disease and Guillain-Barre syndrome. Eur J Neurol. 2003;10:600.
15. Aimoto Y, Ito K, Moriwaka F, Tashiro K, Abe K. Demyelinating peripheral neuropathy in Devic disease. Jpn J Psychiatry Neurol. 1991;45:861-4.
16. Sato S, Nakamura A, Iwahashi T, Morita H, Hashimoto T, Ikeda S. Simultaneous exacerbation and remission of central and peripheral demyelination. Muscle Nerve. 2000;23:440-1.
17. Capello E, Roccatagliata L, Schenone A, Gazzola P, Inglese M, Abbruzzese M, et al. Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? Eur J Neurol. 2000;7:223-5.
18. Pareyson D, Ciano C, Fiacchino F, Gemma M, Savoiardo M, Sghirlanzoni A. Combined central and peripheral acute demyelination. Ital J Neurol Sci. 1993;14:83-6.
19. Best PV. Acute polyradiculoneuritis associated with demyelinated plaques in the central nervous system: report of a case. Acta Neuropathol. 1985;67:230-4.
20. Lassmann H, Budka H, Schnaberth G. Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch Neurol. 1981;38:99-102.
21. Forrester C, Lascelles RG. Association between polyneuritis and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1979;42:864-6.
22. Sato N, Watanabe K, Ohta K, Tanaka H. Acute transverse myelitis and acute motor axonal neuropathy developed after vaccinations against seasonal and 2009 A/H1N1 influenza. Intern Med. 2011;50:503-7.
23. Tripp A. Acute transverse myelitis and Guillain-Barre overlap syndrome following influenza infection. CNS Spectr. 2008; 13:744-6.
24. Saidha S, Renganathan R, Spillane J, McNamara B, Fanning N, Ryan AM. Simultaneous transverse myelitis and acute motor axonal neuropathy in an adult. J Neurol Neurosurg Psychiatry. 2008;79:1302-3.
25. Howell KB, Wanigasinghe J, Leventer RJ, Ryan MM. Concomitant transverse myelitis and acute motor axonal neuropathy in an adolescent. Pediatr Neurol. 2007;37:378-81.
26. Nakamura N, Nokura K, Zettsu T, Koga H, Tachi M, Terada M, et al. Neurologic complications associated with influenza vaccination: two adult cases. Intern Med. 2003;42:191-4.
27. Chua HC, Tjia H, Sitoh YY. Concurrent myelitis and Guillain-Barre syndrome after varicella infection. Int J Clin Pract. 2001;55:643-4.
28. Martens-Le Bouar H, Korinthenberg R. Polyradiculoneuritis with myelitis: a rare differential diagnosis of Guillain-Barre syndrome. Neuropediatrics. 2002;33:93-6.
29. Tomiyasu K, Ishiyama M, Kato K, Komura M, Ohnuma E, Inamasu J, et al. Bilateral retrobulbar optic neuritis, Guillain-Barre syndrome and asymptomatic central white matter lesions following adult measles infection. Intern Med. 2009;48:377-81.
30. An JY, Yoon B, Kim JS, Song IU, Lee KS, Kim YI. Guillain-Barre syndrome with optic neuritis and a focal lesion in the central white matter following Epstein-Barr virus infection. Intern Med. 2008;47:1539-42.
31. Echaniz-Laguna A, Battaglia F, Heymann R, Tranchant C, Warter JM. The Miller Fisher syndrome: neurophysiological and MRI evidence of both peripheral and central origin in one case. J Neurol. 2000;247:980-2.
32. Katchanov J, Lunemann JD, Masuhr F, Becker D, Ahmadi M, Bosel J, et al. Acute combined central and peripheral inflammatory demyelination. J Neurol Neurosurg Psychiatry. 2004;75:1784-6.
33. Okumura A, Ushida H, Maruyama K, Itomi K, Ishiguro Y, Takahashi M, et al. Guillain-Barre syndrome associated with central nervous system lesions. Arch Dis Child. 2002;86:304-6.
34. Borruat FX, Schatz NJ, Glaser JS, Forteza A. Central nervous system involvement in Guillain-Barre-like syndrome: clinical and magnetic resonance imaging evidence. Eur Neurol. 1997;38:129-31.
35. Urushitani M, Udaka F, Kameyama M. Miller Fisher-Guillain-Barre overlap syndrome with enhancing lesions in the spinocerebellar tracts. J Neurol Neurosurg Psychiatry. 1995;58:241-3.
36. Tezer FI, Gurer G, Karatas H, Nurlu G, Saribas O. Involvement of the central nervous system in Miller Fisher syndrome: a case report. Clin Neurol Neurosurg. 2002;104:377-9.
37. Giroud M, Mousson C, Chalopin JM, Rifle G, Dumas R. Miller-Fisher syndrome and pontine abnormalities on MRI: a case report. J Neurol. 1990;237:489-90.
38. Ferrer X, Ellie E, Larriviere M, Deleplanque B, Lagueny A, Julien J. Late central demyelination after Fischer’s syndrome: MRI studies. J Neurol Neurosurg Psychiatry. 1993;56:698-9.
39. Derakhshan I, Lotfi J, Kaufman B. Ophthalmoplegia, ataxia and hyporeflexia (Fisher’s syndrome). With a midbrain lesion demonstrated by CT scanning. Eur Neurol. 1979;18:361-6.
40. Barontini F, Sita D. The nosological position of Fisher’s syndrome (ophthalmoplegia, ataxia and areflexia). J Neurol. 1983;229:33-44.
41. Taphoorn MJ, Lanting P, Hazenberg GJ, Uitdehaag BJ, Kaiser MC. Observations on the lesion site in the Miller Fisher syndrome: presentation of a case including CT and MRI. Acta Neurol Scand. 1989;80:167-9.
42. Lolekha P, Phanthumchinda K. Optic neuritis in a patient with Miller-Fisher syndrome. J Med Assoc Thai. 2008;91:1909-13.
43. Igarashi O, Fujioka T, Kishi M, Normoto N, Iwasaki Y, Kurihara T. Guillain-Barre syndrome with optic neuritis and cytomegalovirus infection. J Peripher Nerv Syst. 2005;10:340-1.
44. Ginestal RC, Plaza JF, Callejo JM, Rodriguez-Espinosa N, Fernandez-Ruiz LC, Masjuan J. Bilateral optic neuritis and Guillain-Barre syndrome following an acute Mycoplasma pneumoniae infection. J Neurol. 2004;251:767-8.
45. Chan JW. Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome. Br J Ophthalmol. 2003;87:1185-6.
46. Pfausler B, Engelhardt K, Kampfl A, Spiss H, Taferner E, Schmutzhard E. Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature. Eur J Neurol. 2002;9:93-6.
47. Colding-Jorgensen E, Vissing J. Visual impairment in anti-GQ1b positive Miller Fisher syndrome. Acta Neurol Scand. 2001;103:259-60.
48. Henderson RD, Ohlrich GD, Pender MP. Guillain-Barre syndrome and optic neuritis after Mycoplasma pneumoniae infection. Aust N Z J Med. 1998;28:481-2.
49. Phanthumchinda K, Intragumtornchai T, Kasantikul V. Guillain-Barre syndrome and optic neuropathy in acute leukemia. Neurology. 1988;38:1324-6.
50. Uncini A, Treviso M, Basciani M, Onofrj M, Gambi D. Associated central and peripheral demyelination: an electrophysiological study. J Neurol. 1988;235:238-40.
51. Toshniwal P. Demyelinating optic neuropathy with Miller-Fisher syndrome. The case for overlap syndromes with central and peripheral demyelination. J Neurol. 1987;234:353-8.
52. Behan PO, Lessell S, Roche M. Optic neuritis in the Landry-Guillain-Barre-Strohl syndrome. Br J Ophthalmol. 1976;60:58-9.
53. Mao Z, Luo C, Ou S, Xue-an M. Coexistence of Guillain-Barré syndrome and transverse myelitis: a case report. Chin J Neurol. 2012;45:835-6.
54. Chmura Kraemer H, Periyakoil VS, Noda A. Kappa coefficients in medical research. Stat Med. 2002;21:2109-29.
55. Ruts L, Drenthen J, Jongen JL, Hop WC, Visser GH, Jacobs BC, et al. Pain in Guillain-Barre syndrome: a long-term followup study. Neurology. 2010;75:1439-47.
56. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet. 1978;2:750-3.
57. Wu JS, Zhang MN, Carroll WM, Kermode AG. Characterisation of the spectrum of demyelinating disease in Western Australia. J Neurol Neurosurg Psychiatry. 2008;79:1022-6.
58. Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009;72:232-9.
59. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol. 2008;7:939-50.
60. Ketelslegers IA, Catsman-Berrevoets CE, Neuteboom RF, Boon M, van Dijk KG, Eikelenboom MJ, et al. Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study. J Neurol. 2012;259(9):1929-35.
61. Pohl D. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions. Curr Opin Neurol. 2008;21:366-72.
62. Dourado ME, Felix RH, da Silva WK, Queiroz JW, Jeronimo SM. Clinical characteristics of Guillain-Barre syndrome in a tropical country: a Brazilian experience. Acta Neurol Scand. 2011;125:47-53.
63. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain-Barre syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry. 1997;63:494-500.
64. Aranyi Z, Kovacs T, Sipos I, Bereczki D. Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol. 2012;19(15-20):e11-3.
65. Wong V. A neurophysiological study in children with Miller Fisher syndrome and Guillain-Barre syndrome. Brain Dev. 1997;19:197-204.
66. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911-7.